The Addition of Romidepsin to CHOEP and High-Dose Chemotherapy Plus Stem Cell Transplantation Did Not Ameliorate the Outcome of Untreated Angioimmunoblastic T-Cell or Follicular T-Helper Lymphoma: Subgroup Analysis of Phase II FIL-PTCL13 Study

被引:0
|
作者
Chiappella, Annalisa [1 ]
Dodero, Anna [2 ]
Evangelista, Andrea [3 ]
Re, Alessandro [4 ]
Orsucci, Lorella [5 ]
Usai, Sara Veronica [6 ]
Castellino, Claudia [7 ]
Stefoni, Vittorio [8 ]
Pinto, Antonio [9 ]
Zanni, Manuela [10 ]
Ciancia, Rosanna [11 ]
Ghiggi, Chiara [12 ]
Rossi, Francesca Gaia [13 ]
Arcari, Annalisa [14 ]
Ilariucci, Fiorella [15 ]
Zilioli, Vittorio Ruggero [16 ]
Flenghi, Leonardo [17 ]
Celli, Melania [18 ]
Volpetti, Stefano [19 ]
Benedetti, Fabio [20 ]
Ballerini, Filippo [21 ]
Musuraca, Gerardo [22 ]
Bruna, Riccardo [23 ]
Patti, Caterina [24 ]
Leonardi, Francesco [25 ]
Arcaini, Luca [26 ,27 ]
Magagnoli, Massimo [28 ]
Cavallo, Federica [29 ]
Tabanelli, Valentina [30 ]
Ciccone, Giovannino [31 ]
Pileri, Stefano A. [32 ]
Corradini, Paolo [33 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Div Hematol & Stem Cell Transplant, Milan, Italy
[2] Fdn IRCCS Ist Nazl Tumori, Hematol, Milan, Italy
[3] Unit Clin Epidemiol Citta Salute & Sci Torino, Turin, Italy
[4] ASST Spedali Civili, Dept Hematol, Brescia, Italy
[5] Citte Salute Hosp & Univ, Hematol, Turin, Italy
[6] Osped Oncol Armando Businco, Hematol, Cagliari, Italy
[7] Azienda Osped S Croce & Carle, Div Hematol, Cuneo, Italy
[8] Univ Bologna, Dept Translat & Precis Med, Hematol, Bologna, Italy
[9] Fdn G Pascale, Natl Canc Inst, Dept Hematol & Innovat Therapies, Hematol Oncol & Stem Cell Transplantat Unit,IRCCS, Naples, Italy
[10] Azienda Osped Santi Antonio & Biagio & Cesare Arr, Div Hematol, Alessandria, Italy
[11] Ctr Riferimento Oncol CRO IRCCS, Oncohematol & Stem Cell Transplantat & Cellular T, Aviano, Italy
[12] IRCCS Osped Policlin San Martino, Hematol, Genoa, Italy
[13] Fdn IRCCS Ca Granda, Div Hematol, OM Policlin, Milan, Italy
[14] Osped Guglielmo Saliceto, Hematol Unit, Piacenza, Italy
[15] Azienda Ausl IRCCS Santa Maria Nuova Reggio Emili, Reggio Emilia, Italy
[16] ASST Grande Osped Metropolitano Niguarda, Div Hematol, Milan, Italy
[17] Osped S Maria Misericordia, Hematol, Perugia, Italy
[18] Osped Infermi Rimini, UO Ematol, Rimini, Italy
[19] Presidio Osped Univ Santa Maria Misericordia Udin, ASUFC, Clin Hematol, Udine, Italy
[20] Azienda Osped Univ Verona, Hematol & Stem Cell Transplantat, Verona, Italy
[21] IRCCS Osped Policlin San Martino, Clin Hematol, Dept Internal Med DiMI, Genoa, Italy
[22] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Div Hematol, Meldola, Italy
[23] Osped Maggiore La Carita, Div Hematol, Novara, Italy
[24] Azienda Villa Sofia Cervello, Div Onco Hematol, Palermo, Italy
[25] Azienda Osped Univ Parma, Hematol & CTMO, Parma, Italy
[26] Fdn IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy
[27] Univ Pavia, Dept Mol Med, Pavia, Italy
[28] IRCCS Humanitas Res Hosp, Hematol, Rozzano Milano, Italy
[29] AOU Citta Salute & Sci Torino, Div Hematol, Turin, Italy
[30] IEO Ist Europeo Oncol IRCCS, Div Diagnost Haematopathol, Milan, Italy
[31] AOU Citta Salute & Sci Torino, Unit Canc Epidemiol, CPO Piemonte, Turin, Italy
[32] IEO Ist Europeo Oncol IRCCS, Hematopathol Div, Milan, Italy
[33] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Milan, Italy
关键词
D O I
10.1182/blood-2022-163824
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:6538 / 6539
页数:2
相关论文
共 46 条
  • [1] THE ADDITION OF ROMIDEPSIN TO CHOEP PLUS UP-FRONT STEM-CELL TRANSPLANTATION IS NOT EFFECTIVE IN PERIPHERAL T-CELL LYMPHOMA (PTCL): FIRST ANALYSIS OF THE PHASE II FIL-PTCL13 STUDY
    Chiappella, A.
    Carniti, C.
    Re, A.
    Castellino, C.
    Evangelista, A.
    Ciancia, R.
    Orsucci, L.
    Pinto, A.
    Usai, S. V.
    Arcari, A.
    Ilariucci, F.
    Rossi, F. G.
    Benedetti, F.
    Flenghi, L.
    Ghiggi, C.
    Molinari, A. L.
    Stefoni, V.
    Volpetti, S.
    Zilioli, V. R.
    Ballerini, F.
    Bruna, R.
    Cavallo, F.
    Musuraca, G.
    Patti, C.
    Re, F.
    Tani, M.
    Varettoni, M.
    Zanni, M.
    Dodero, A.
    Pileri, S.
    Ciccone, G.
    Corradini, P.
    HAEMATOLOGICA, 2021, 106 (10) : 10 - 11
  • [2] Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
    Annalisa Chiappella
    Anna Dodero
    Andrea Evangelista
    Alessandro Re
    Lorella Orsucci
    Sara Veronica Usai
    Claudia Castellino
    Vittorio Stefoni
    Antonio Pinto
    Manuela Zanni
    Rosanna Ciancia
    Chiara Ghiggi
    Francesca Gaia Rossi
    Annalisa Arcari
    Fiorella Ilariucci
    Vittorio Ruggero Zilioli
    Leonardo Flenghi
    Melania Celli
    Stefano Volpetti
    Fabio Benedetti
    Filippo Ballerini
    Gerardo Musuraca
    Riccardo Bruna
    Caterina Patti
    Francesco Leonardi
    Luca Arcaini
    Massimo Magagnoli
    Federica Cavallo
    Anisa Bermema
    Alessandra Tucci
    Carola Boccomini
    Giovannino Ciccone
    Cristiana Carniti
    Stefano Aldo Pileri
    Paolo Corradini
    Leukemia, 2023, 37 : 433 - 440
  • [3] Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
    Chiappella, Annalisa
    Dodero, Anna
    Evangelista, Andrea
    Re, Alessandro
    Orsucci, Lorella
    Usai, Sara Veronica
    Castellino, Claudia
    Stefoni, Vittorio
    Pinto, Antonio
    Zanni, Manuela
    Ciancia, Rosanna
    Ghiggi, Chiara
    Rossi, Francesca Gaia
    Arcari, Annalisa
    Ilariucci, Fiorella
    Zilioli, Vittorio Ruggero
    Flenghi, Leonardo
    Celli, Melania
    Volpetti, Stefano
    Benedetti, Fabio
    Ballerini, Filippo
    Musuraca, Gerardo
    Bruna, Riccardo
    Patti, Caterina
    Leonardi, Francesco
    Arcaini, Luca
    Magagnoli, Massimo
    Cavallo, Federica
    Bermema, Anisa
    Tucci, Alessandra
    Boccomini, Carola
    Ciccone, Giovannino
    Carniti, Cristiana
    Pileri, Stefano Aldo
    Corradini, Paolo
    LEUKEMIA, 2023, 37 (02) : 433 - 440
  • [4] Multicenter phase II study of romidepsin plus lenalidomide for patients with previously untreated peripheral T-cell lymphoma (PTCL).
    Ruan, Jia
    Zain, Jasmine M.
    Palmer, Brett
    Jovanovic, Borko
    Mi, Xinlei
    Swaroop, Alok
    Winter, Jane
    Gordon, Leo I.
    Karmali, Reem
    Pro, Barbara
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] ROMIDEPSIN-CHOEP PLUS UP-FRONT STEM-CELL TRANSPLANTATION IN PERIPHERAL T-CELL LYMPHOMA (PTCL): RESULTS OF PHASE IB PTCL13 STUDY OF THE FONDAZIONE ITALIANA LINFOMI
    Chiappella, A.
    Carniti, C.
    Evangelista, A.
    Re, A.
    Cabras, M. G.
    Stefoni, V.
    Castellino, C.
    Congiu, A. G.
    Pinto, A.
    Zanni, M.
    Rusconi, C.
    Molinari, A. L.
    Ciancia, R.
    Baldini, L.
    Nassi, L.
    Re, F.
    Tani, M.
    Ilariucci, F.
    Cavallo, F.
    Santoro, A.
    Volpetti, S.
    Dodero, A.
    Pileri, S.
    Ciccone, G.
    Corradini, P.
    HAEMATOLOGICA, 2019, 104 : 48 - 48
  • [6] Treatment of peripheral T-cell lymphoma (PTCL) with high-dose chemotherapy and autologous stem cell transplantation (ASCT).
    Kim, Min Kyoung
    Kim, Shin
    Lee, Seoung Sook
    Sym, Sun Jin
    Lee, Dae Ho
    Kim, Sang We
    Jang, Seongsoo
    Park, Chan Jeong
    Chi, Hyun Sook
    Huh, Joo Ryung
    Sub, Cheolwon
    BLOOD, 2006, 108 (11) : 252B - 252B
  • [7] Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma.
    Khan, Niloufer
    Khimani, Farhad
    Shustov, Andrei R.
    Shadman, Mazyar
    Ruan, Jia
    Moskowitz, Alison J.
    Straus, David J.
    Kumar, Anita
    Sauter, Craig Steven
    Zelenetz, Andrew David
    Noy, Ariela
    Shah, Gunjan L.
    Matasar, Matthew J.
    Drullinsky, Pamela
    Hamilton, Audrey M.
    Drill, Esther N.
    Van Besien, Koen
    Giralt, Sergio
    Horwitz, Steven M.
    Dahi, Parastoo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
    Khan, Niloufer
    Shustov, Andrei R.
    Khimani, Farhad
    Shadman, Mazyar
    Cassaday, Ryan D.
    Ruan, Jia
    Moskowitz, Alison J.
    Zelenetz, Andrew D.
    Noy, Ariela
    Straus, David J.
    Drullinsky, Pamela
    Hamilton, Audrey
    Kumar, Anita
    Sauter, Craig S.
    Shah, Gunjan L.
    Matasar, Matthew J.
    Drill, Esther
    Davey, Theresa
    Hancock, Helen
    Bahgat, Alexandra
    Blouin, William
    Schiavo, Karen Marie
    Smith, Heather
    Van Besien, Koen
    Giralt, Sergio A.
    Horwitz, Steven M.
    Dahi, Parastoo B.
    BLOOD, 2019, 134
  • [9] Romidepsin-CHOEP Plus Intensification with up-Front Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: Final Results of Phase Ib PTCL13 Study of the Fondazione Italiana Linfomi
    Chiappella, Annalisa
    Carniti, Cristiana
    Evangelista, Andrea
    Cabras, Maria Giuseppina
    Re, Alessandro
    Zanni, Manuela
    Stefoni, Vittorio
    Santoro, Armando
    Congiu, Angela Giovanna
    Dodero, Anna
    Pileri, Stefano A.
    Ciccone, Giovannino
    Corradini, Paolo
    BLOOD, 2018, 132
  • [10] Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.: The GELTAMO experience
    Rodriguez, Jose
    Conde, Eulogio
    Gutierrez, Antonio
    Arranz, Reyes
    Gandarillas, Marcos
    Leon, Angel
    Ojanguren, Jesus
    Sureda, Anna
    Carrera, Dolores
    Bendandi, Mauricio
    Moraleda, Jose
    Ribera, Jose Maria
    Albo, Carmen
    Morales, Alfonso
    Garcia, Juan Carlos
    Fernandez, Pascual
    Canigral, Guillermo
    Bergua, Juan
    Caballero, Maria Dolores
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 78 (04) : 290 - 296